Log in to save to my catalogue

Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease

Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_927689260

Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease

Publication information

Publisher

Waltham, MA: Massachusetts Medical Society

More information

Scope and Contents

Contents

In patients with moderate or severe Alzheimer's disease receiving donepezil, those assigned to continue donepezil had less cognitive decline than did those assigned to discontinue donepezil. The combination of donepezil and memantine did not confer benefits over donepezil alone.
Most studies evaluating cholinesterase inhibitors for the treatment...

Alternative Titles

Full title

Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_927689260

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_927689260

Other Identifiers

ISSN

0028-4793,1533-4406

E-ISSN

1533-4406

DOI

10.1056/NEJMoa1106668

How to access this item